This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

Profil

de Marneffe Nils

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Lancellotti, Patrizio  (10)
Dulgheru, Raluca Elena  (5)
Damas, François  (3)
Petitjean, Hélène  (3)
Hanoul, Chloé  (2)
Main Referenced Keywords
Humans (5); Hypertrophic cardiomyopathy (2); Mavacamten (2); Recommendations (2); Treatment (2);
Main Referenced Disciplines
Cardiovascular & respiratory systems (10)

Publications (total 10)

The most downloaded
868 downloads
DE MARNEFFE, N., Dulgheru, R. E., Ancion, A., Moonen, M., & Lancellotti, P. (2022). Cardiac amyloidosis: a review of the literature. Acta Cardiologica, 1-10. doi:10.1080/00015385.2021.1992990 https://hdl.handle.net/2268/293902

The most cited

21 citations (OpenAlex)

DE MARNEFFE, N., Dulgheru, R. E., Ancion, A., Moonen, M., & Lancellotti, P. (2022). Cardiac amyloidosis: a review of the literature. Acta Cardiologica, 1-10. doi:10.1080/00015385.2021.1992990 https://hdl.handle.net/2268/293902

Restelli, D., VAN WALLENDAEL, C., de Marneffe, N., DAMAS, F., Dulgheru, R. E., & Lancellotti, P. (25 February 2025). One-Year Echocardiographic Follow-Up in Transthyretin Cardiac Amyloidosis: Impact of Tafamidis Treatment. Journal of Clinical Medicine, 14 (5), 1538. doi:10.3390/jcm14051538
Peer Reviewed verified by ORBi

Lancellotti, P., de Marneffe, N., & Scheen, A. (February 2024). Le médicament du moisMavacamten (Camzyos®) : premier inhibiteur réversible de l’ATP-ase de la myosine pour le traitement des cardiomyopathies hypertrophiques obstructives. Revue Médicale de Liège, 79 (2), 120-128.
Editorial Reviewed verified by ORBi

Hanoul, C., de Marneffe, N., Dulgheru, R. E., DAMAS, F., Tajildin, R., PETITJEAN, H., & Lancellotti, P. (December 2023). Sténose aortique : nouveautés thérapeutiques et diagnostiques. Revue Médicale de Liège, 78 (12), 689-694.
Editorial Reviewed verified by ORBi

PETITJEAN, H., de Marneffe, N., Nguyen Trung, M.-L., Hanoul, C., Rorive, A., Moonen, M., & Lancellotti, P. (December 2023). Cardio-oncologie et cardio-obstétrique : importance d’une approche multidisciplinaire. Revue Médicale de Liège, 78 (12), 695-702.
Editorial Reviewed verified by ORBi

Lancellotti, P., MASSON, A., DAMAS, F., & de Marneffe, N. (November 2023). Nouvelles recommandations pour le diagnostic et la prise en charge thérapeutique de la cardiomyopathie hypertrophique. Revue Médicale de Liège, 78 (11), 619-625.
Editorial Reviewed verified by ORBi

Lancellotti, P., PETITJEAN, H., de Marneffe, N., & Cosyns, B. (November 2022). Focus issue on cardiomyopathies. Acta Cardiologica, 77 (9), 765-767. doi:10.1080/00015385.2022.2158618
Editorial reviewed

DE MARNEFFE, N., Dulgheru, R. E., Ancion, A., Moonen, M., & Lancellotti, P. (2022). Cardiac amyloidosis: a review of the literature. Acta Cardiologica, 1-10. doi:10.1080/00015385.2021.1992990
Peer Reviewed verified by ORBi

Ilardi, F., Postolache, A., Dulgheru, R., Trung, M.-L. N., DE MARNEFFE, N., Sugimoto, T., Go, Y. Y., Oury, C., Esposito, G., & LANCELLOTTI, P. (11 March 2022). Prognostic Value of Non-Invasive Global Myocardial Work in Asymptomatic Aortic Stenosis. Journal of Clinical Medicine, 11 (6). doi:10.3390/jcm11061555
Peer Reviewed verified by ORBi

Dulgheru, R. E., DE MARNEFFE, N., & Lancellotti, P. (December 2021). Amylose cardiaque à transthyrétine de type sénile et sténose aortique - ne manquez pas le diagnostic ! Journal de Cardiologie, 12, 24-27.
Peer reviewed

Dulgheru, R. E., de Marneffe, N., & Lancellotti, P. (December 2021). AMYLOSE CARDIAQUE A TRANSTHYRETINE DE TYPE SENILE ET STENOSE AORTIQUE - NE MANQUEZ PAS LE DIAGNOSTIQUE. Journal de Cardiologie, EDITION SPECIALE (DECEMBRE 2021), 24.
Peer reviewed

Contact ORBi